Dominic Rodrigues
Contributor since: 2013
"Connecting The Dots"
Waiting For Godot
Counting Down
You Gotta Do What You Gotta Do
Upping The Volume
Awakening At Provectus
I Wait. You Wait. He/She Waits. They Wait.
Single Injection May Revolutionize Melanoma Treatment, Moffitt Study Shows
It All Begins And Ends With Rose Bengal
Arguing For My $PVCT Investment Thesis (Pt. 1)
The Beginning Of The End[-game] For $PVCT
A More Aggressive Pathway To Approval For $PVCT
$PVCT: Moving On, Moving Up
For $PVCT, It's The FDA's Move
I Think The Situation With $PFE And $PVCT Has Escalated
How Could A Provectus-Pfizer Story Unfold?
I Think It's A Good Time To Be A $PVCT Shareholder
Daiichi Sankyo: A Dark Horse Challenger To Big Pharma Buying $PVCT
A Fool's Game, A Grand Quest, And Part I Of An Epic Outcome
$PVCT: Florey, Chain & Heatley
$PVCT #AACR2013 Thoughts...
Why I Am Long Provectus Pharmaceuticals (Updated)
$PVCT's #China #Pharma Process In More Detail
$PVCT's Prospective #China #Pharma Partner Is...
$PVCT: Timing Provectus
$PVCT: $CLSN, The @adamfeuerstein-Ratain Rule, And Provectus In China
$PVCT: March Madness 2013
$PVCT: Get Shorty (Update)
$PVCT: Immunologic Potential, And Thus Value
$PVCT: Will Management Get A Deal Done In China?
$PVCT.OB: The Orthogonality Paradigm
$PVCT At The SITC 27th Annual Meeting